Cargando…
Quantitative Profiling of the Effects of Vanoxerine on Human Cardiac Ion Channels and its Application to Cardiac Risk
Vanoxerine has been in clinical trials for Parkinsonism, depression and cocaine addiction but lacked efficacy. Although a potent blocker of hERG, it produced no serious adverse events. We attributed the unexpected result to offsetting Multiple Ion Channel Effects (MICE). Vanoxerine’s effects were st...
Autores principales: | Obejero-Paz, Carlos A., Bruening-Wright, Andrew, Kramer, James, Hawryluk, Peter, Tatalovic, Milos, Dittrich, Howard C., Brown, Arthur M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663487/ https://www.ncbi.nlm.nih.gov/pubmed/26616666 http://dx.doi.org/10.1038/srep17623 |
Ejemplares similares
-
Vanoxerine kills mycobacteria through membrane depolarization and efflux inhibition
por: Kingdon, Alexander D. H., et al.
Publicado: (2023) -
MICE Models: Superior to the HERG Model in Predicting Torsade de Pointes
por: Kramer, James, et al.
Publicado: (2013) -
Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma
por: Zhu, Ying, et al.
Publicado: (2021) -
Ni(2+) Block of Ca(V)3.1 (α1G) T-type Calcium Channels
por: Obejero-Paz, Carlos A., et al.
Publicado: (2008) -
Y(3+) Block Demonstrates an Intracellular Activation Gate for the α1G T-type Ca(2+) Channel
por: Obejero-Paz, Carlos A., et al.
Publicado: (2004)